Spruce Biosciences, Inc. (SPRB)
NASDAQ·Healthcare·Biotechnology
$44.55
+3.27%
Mkt Cap $36.05M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$191.00
Range $140.00 – $283.00
Implied Upside
+328.7%
Consensus $191.00 vs current $44.55
NASDAQ·Healthcare·Biotechnology
$44.55
+3.27%
Mkt Cap $36.05M
No recent rating data.
Price Target (6 analysts)
$191.00
Range $140.00 – $283.00
+328.7%
Consensus $191.00 vs current $44.55